NOCIL [NOCIL] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison
NOCIL
NSE
Loading...
Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: NOCIL wins in 10 metrics, Grauer & Weil wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | NOCIL | Grauer & Weil | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 31.35 | 27.77 | Grauer & Weil |
| Price-to-Book Ratio | 1.65 | 4.65 | NOCIL |
| Debt-to-Equity Ratio | 0.58 | 1.26 | NOCIL |
| PEG Ratio | 16.37 | 38.69 | NOCIL |
| EV/EBITDA | 22.61 | 20.47 | Grauer & Weil |
| Profit Margin (TTM) | 6.86% | 13.85% | Grauer & Weil |
| Operating Margin (TTM) | 5.03% | 7.46% | Grauer & Weil |
| EBITDA Margin (TTM) | 5.03% | 7.46% | Grauer & Weil |
| Return on Equity | 5.84% | 18.02% | Grauer & Weil |
| Return on Assets (TTM) | 5.00% | 8.70% | Grauer & Weil |
| Free Cash Flow (TTM) | $-975.60M | $999.80M | Grauer & Weil |
| Dividend Yield | 1.08% | 1.05% | NOCIL |
| 1-Year Return | -42.39% | 9.60% | Grauer & Weil |
| Price-to-Sales Ratio (TTM) | 2.15 | 3.85 | NOCIL |
| Enterprise Value | $26.49B | $38.42B | Grauer & Weil |
| EV/Revenue Ratio | 1.95 | 3.39 | NOCIL |
| Gross Profit Margin (TTM) | 42.48% | 41.05% | NOCIL |
| Revenue per Share (TTM) | $81 | $25 | NOCIL |
| Earnings per Share (Diluted) | $5.56 | $3.47 | NOCIL |
| Beta (Stock Volatility) | 0.04 | 0.28 | NOCIL |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
NOCIL vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| NOCIL | 0.01% | -3.34% | -10.09% | -2.61% | -19.60% | -31.05% |
| Grauer & Weil | 1.47% | -0.52% | -8.37% | 18.19% | 0.93% | -8.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| NOCIL | -42.39% | -34.67% | 54.21% | 283.56% | 701.52% | 453.43% |
| Grauer & Weil | 9.60% | 47.21% | 147.69% | 405.77% | 1,019.05% | 755.68% |
Performance & Financial Health Analysis: NOCIL vs Grauer & Weil
| Metric | NOCIL | GRAUWEIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹29.12B | ₹43.69B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 271,223 | 133,480 |
| 90 Day Avg. Volume | 442,188 | 191,775 |
| Last Close | ₹174.33 | ₹96.35 |
| 52 Week Range | ₹158.10 - ₹309.00 | ₹78.00 - ₹120.00 |
| % from 52W High | -43.58% | -19.71% |
| All-Time High | ₹336.00 (Jul 29, 2024) | ₹204.80 (Feb 26, 2024) |
| % from All-Time High | -48.12% | -52.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.10% | 0.02% |
| Quarterly Earnings Growth | -0.36% | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.14% |
| Operating Margin (TTM) | 0.05% | 0.07% |
| Return on Equity (TTM) | 0.06% | 0.18% |
| Debt to Equity (MRQ) | 0.58 | 1.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹105.51 | ₹20.72 |
| Cash per Share (MRQ) | ₹16.37 | ₹11.87 |
| Operating Cash Flow (TTM) | ₹165.80M | ₹1.44B |
| Levered Free Cash Flow (TTM) | ₹1.03B | ₹927.08M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.08% | 1.05% |
| Last 12-Month Dividend | ₹2.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: NOCIL vs Grauer & Weil
| Metric | NOCIL | GRAUWEIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 31.35 | 27.77 |
| Forward P/E | 16.37 | 38.69 |
| PEG Ratio | 16.37 | 38.69 |
| Price to Sales (TTM) | 2.15 | 3.85 |
| Price to Book (MRQ) | 1.65 | 4.65 |
| Market Capitalization | ||
| Market Capitalization | ₹29.12B | ₹43.69B |
| Enterprise Value | ₹26.49B | ₹38.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.95 | 3.39 |
| Enterprise to EBITDA | 22.61 | 20.47 |
| Risk & Other Metrics | ||
| Beta | 0.04 | 0.28 |
| Book Value per Share (MRQ) | ₹105.51 | ₹20.72 |
Financial Statements Comparison: NOCIL vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NOCIL | GRAUWEIL |
|---|---|---|
| Revenue/Sales | ₹3.36B | ₹3.40B |
| Cost of Goods Sold | ₹1.93B | ₹2.00B |
| Gross Profit | ₹1.43B | ₹1.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹169.10M | ₹237.20M |
| EBITDA | ₹371.80M | ₹417.40M |
| Pre-Tax Income | ₹231.40M | ₹343.50M |
| Income Tax | ₹58.80M | ₹86.10M |
| Net Income (Profit) | ₹172.60M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NOCIL | GRAUWEIL |
|---|---|---|
| Cash & Equivalents | ₹299.40M | ₹1.08B |
| Total Current Assets | ₹9.34B | ₹9.36B |
| Total Current Liabilities | ₹1.60B | ₹2.97B |
| Long-Term Debt | ₹71.30M | ₹37.30M |
| Total Shareholders Equity | ₹17.62B | ₹9.39B |
| Retained Earnings | ₹14.52B | N/A |
| Property, Plant & Equipment | ₹8.51B | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NOCIL | GRAUWEIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NOCIL | GRAUWEIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 271,223 | 133,480 |
| Average Daily Volume (90 Day) | 442,188 | 191,775 |
| Shares Outstanding | 167.02M | 453.41M |
| Float Shares | 87.60M | 127.47M |
| % Held by Insiders | 0.42% | 0.72% |
| % Held by Institutions | 0.08% | 0.00% |
Dividend Analysis & Yield Comparison: NOCIL vs Grauer & Weil
| Metric | NOCIL | GRAUWEIL |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹1.00 |
| Last 12-Month Dividend Yield | 1.08% | 1.05% |
| 3-Year Avg Annual Dividend | ₹2.67 | ₹0.58 |
| 3-Year Avg Dividend Yield | 1.14% | 0.45% |
| 3-Year Total Dividends | ₹8.00 | ₹1.73 |
| Ex-Dividend Date | Jul 30, 2025 | Aug 06, 2025 |